Volver a Agenda
Session Chair(s)
Gary Coward
PAREXEL International, United Kingdom
Learning Objective : Identify three different operational approaches to generating real-world evidence on the usage, effectiveness, and safety of a pharmacological intervention in a late-phase environment; Discuss advantages of adopting a considered risk-based approach to site monitoring; Describe the benefits of using a managed access program; Discuss how to ensure a successful observational study outcome.
Speaker(s)
Generating Momentum in Post-authorization Studies
Gary Coward
PAREXEL International, United Kingdom
Use of Expanded Access Program (EAP) Data to Gain New Insights into Drug Efficacy and Safety
Heather L Manna
Idis Pharma, United States
Senior Manager, Regulatory Affairs
Risk-based Approach to Monitoring in Late-phase Clinical Trials
Bill Row, MBA, MS
Mapi, United States
Senior Director, Clinical Operations Americas
¿Tiene una cuenta?